Sanofi 1Q Net Pft EUR2B
Sanofi SA on Thursday posted higher earnings and sales for the first quarter, driven by best-selling drug Dupixent and consumer healthcare, and said that it expects further growth in business earnings per share during 2022.
Sanofi SA on Thursday posted higher earnings and sales for the first quarter, driven by best-selling drug Dupixent and consumer healthcare, and said that it expects further growth in business earnings per share during 2022.
Earnings beat forecast but sales fall short of consensus; beleaguered shares still jump nearly 20%
U.S. oil prices advance; Russia cuts gas supply to Poland, Bulgaria
Nokia Corp. on Thursday posted a forecast-beating first-quarter net profit as demand for mobile networks remains strong, but cautioned that supply-chain constraints continued to hurt sales, in addition to the timing of patent licensing renewals.
‘Our house view is for a mild U.S. recession,’ Peter Hooper, Deutsche Bank’s global head of economic research, told MarketWatch. ‘What surprises us is that our house call hasn’t become consensus.’
After choppy after-hours session, strong forecast sends shares more than 4% higher
Shares of Metro Inc. MRU, -0.58% dropped 0.58% to C$69.83 Tuesday, in what proved to be an all-around poor trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, -1.53% falling 1.53% to 20,690.81.
Pummeled stocks include Netflix, PayPal and Facebook parent Meta Platforms
Investors fail to properly appreciate Snowflake’s free-cash potential and its value to startups, according to Wolfe Research
Shares of Bank of Montreal BMO, -0.82% shed 0.82% to C$141.44 Monday, in what proved to be an all-around poor trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, -0.82% falling 0.82% to 21,011.89.